Antibiotics? Handle with Care

The main drivers of antimicrobial resistance include the misuse and overuse of antimicrobials; lack of access to clean water, sanitation and hygiene for both humans and animals; poor infection and disease prevention and control in health-care facilities and farms; poor access to quality, affordable medicines, vaccines and diagnostics; lack of awareness and knowledge; and lack of enforcement of legislation. Credit: Bigstock.
The main drivers of antimicrobial resistance include the misuse and overuse of antimicrobials; lack of access to clean water, sanitation and hygiene for both humans and animals; poor infection and disease prevention and control in health-care facilities and farms; poor access to quality, affordable medicines, vaccines and diagnostics; lack of awareness and knowledge; and lack of enforcement of legislation. Credit: Bigstock.
  • by Baher Kamal (madrid)
  • Inter Press Service

MADRID, Nov 11 (IPS) - The following information is based on investigations and studies carried out by the World Health Organisation (WHO) and the Food and Agriculture Organisation (FAO).

Antimicrobials – including antibiotics, antivirals, antifungals and antiparasitics – are medicines used to prevent and treat infections in humans, animals and plants.

What is antimicrobial resistance?

Antimicrobial Resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death.

As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat.

Why is it a global concern?

The emergence and spread of drug-resistant pathogens that have acquired new resistance mechanisms, leading to antimicrobial resistance, continues to threaten our ability to treat common infections.

Especially alarming is the rapid global spread of multi- and pan-resistant bacteria (also known as “superbugs”) that cause infections that are not treatable with existing antimicrobial medicines such as antibiotics.

Furthermore, a lack of access to quality antimicrobials remains a major issue. Antibiotic shortages are affecting countries of all levels of development and especially in health-care systems.

Change or loose

In other words, new antibacterials are urgently needed – for example, to treat carbapenem-resistant gram-negative bacterial infections as identified in the WHO priority pathogen list.

However, if people do not change the way antibiotics are used now, new antibiotics will suffer the same fate as the current ones and become ineffective.

Without effective tools for the prevention and adequate treatment of drug-resistant infections and improved access to existing and new quality-assured antimicrobials, the number of people for whom treatment is failing or who die of infections will increase.

Medical procedures, such as surgery, including caesarean sections or hip replacements, cancer chemotherapy, and organ transplantation, will become more risky.

What accelerates the emergence and spread of antimicrobial resistance?

AMR occurs naturally over time, usually through genetic changes. Antimicrobial resistant organisms are found in people, animals, food, plants and the environment (in water, soil and air).

They can spread from person to person or between people and animals, including from food of animal origin.

The main drivers of antimicrobial resistance include the misuse and overuse of antimicrobials; lack of access to clean water, sanitation and hygiene for both humans and animals; poor infection and disease prevention and control in health-care facilities and farms; poor access to quality, affordable medicines, vaccines and diagnostics; lack of awareness and knowledge; and lack of enforcement of legislation.

Present situation

For common bacterial infections, including urinary tract infections, sepsis, sexually transmitted infections, and some forms of diarrhoea, high rates of resistance against antibiotics frequently used to treat these infections have been observed world-wide, indicating that we are running out of effective antibiotics.

Drug resistance in malaria parasites

Another example is the case of the emergence of drug-resistant parasites which possess one of the greatest threats to malaria control and results in increased malaria morbidity and mortality.

Drug resistance in fungi

The prevalence of drug-resistant fungal infections is exasperating the already difficult treatment situation. Many fungal infections have existing treatability issues such as toxicity especially for patients with other underlying infections (e.g. HIV).

This is leading to more difficult to treat fungal infections, treatment failures, longer hospital stays and much more expensive treatment options.

A week to raise awareness

This year’s World Antimicrobial Awareness Week (WAAW) marked 18 to 24 November was previously called the World Antibiotic Awareness Week.

But from 2020, it would be called the World Antimicrobial Awareness Week to include all antimicrobials including antibiotics, antifungals, antiparasitics and antivirals.

The Week is a global campaign aiming at raising awareness of antimicrobial resistance worldwide and encouraging best practices among the general public, health workers and policy makers to slow the development and spread of drug-resistant infections.

Is obtaining more and more commercial benefits a reason enough to transform the healers into killers?

© Inter Press Service (2021) — All Rights Reserved. Original source: Inter Press Service